GENEVA, Aug. 31 -- AZALEA THERAPEUTICS, INC. filed a patent application (US2026/016135) for “T CELL-TARGETED DELIVERY VEHICLES”. With publication no. WO/2026/178423, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: none
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....